NASDAQ · Biotechnology

Aspire-Lakewood Holdings, Inc. (ASBP) Stock

$8.30 +0.00% NASDAQ: ASBP Healthcare

Valuation

MetricValue
Price$8.30
Market Cap$957588
P/E Ratio-1.03
P/B Ratio0.73
P/S Ratio9.81
EPS (TTM)$0.00
52-Week High$562.80
52-Week Low$0.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE199.43%
ROA-81.60%
ROCE-59.81%
Gross Margin0.00%
Operating Margin0.00%
Net Margin-340.40%
Debt/Equity-0.17
Current Ratio0.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$-1.0M$-1.0M$-1.0M$-19.0M
Net Profit$0$3.0M$4.0M$-1.0M$-24.0M
EPS$-0.04$3.72$9.31$-34.17$-16.38
Op Margin————-312017.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$300.0M$20.0M$0$1.0M
Total Liabilities$0$11.0M$0$2.0M$8.0M
Cash$0$0$0$0$1.0M
Borrowings$0$0$0$1.0M$1.0M

Latest News

OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD Zacks Small Cap Research · Jul 10, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs ACCESS Newswire · Jun 24, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026 Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th GlobeNewswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-1.0M$0$-5.0M
Investing Cash Flow$0$-10.0M$285.0M$0$0
Financing Cash Flow$0$4.0M$-285.0M$-2.0M$-1.0M
Net Cash Flow$0$0$0$0$1.0M
Free Cash Flow$0$-5.0M$-1.0M$0$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-3.41
FCF Yield-750.41%
Quick Ratio7.81
Interest Coverage-0.76
Return 1Y-52.52%
Return 3Y-98.56%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANNAAleAnna, Inc. $2.57 +0.78% 13.62 $105.22M 0.00%
BOCNBlue Ocean Acquisition Corp. $10.72 — 46.59 $70.57M 0.00%
CAUDCollective Audience, Inc. $0.00 — 0.00 $20000 0.00%
CHAACatcha Investment Corp $8.90 +7.23% -18.94 $77.57M 0.00%
CSLMConsilium Acquisition Corp I, Ltd. $11.69 +0.00% 1.11 $71.50M 0.00%

About Aspire-Lakewood Holdings, Inc.

Aspire-Lakewood Holdings, Inc. is led by CEO Kraig T. Higginson, employs 2 people, headquartered in US, publicly traded since 2025.

Aspire-Lakewood Holdings, Inc. (ASBP) stock trades at $8.30 with a market capitalization of $957588. The stock is valued at a price-to-earnings (P/E) ratio of -1.03, price-to-book of 0.73, price-to-sales of 9.81. Over the past 52 weeks the stock has ranged between $0.11 and $562.80, and currently trades 98.5% below its 52-week high.

On profitability, Aspire-Lakewood Holdings, Inc. generates a return on equity (ROE) of 199.43% — well above the market average, a sign of a high-quality business, return on capital employed of -59.81%, an operating margin of 0.00%, a net profit margin of -340.40%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides